HDCN-- Weekly Update

H: Special problems -- Obesity, Insulin Resistance
Is the Metabolic Syndrome a Single Construct in Chronic Kidney Disease? Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

CRF: Problem Areas -- Outcomes (Morbidity, Mortality)
P-Cresol Free Serum Concentrations Independently Predict Cardiovascular Disease in Early Stages of CKD.
CRF: Problem areas -- Pre-ESRD care, initiation of dialysis
Phosphate Binder Use and Outcomes in Non-Dialysis Dependent Chronic Kidney Disease.
CRF by problem area -- Anemia/Erythropoietin/Iron
Propensity-Matched Analysis of Early Versus Delayed Initiation of ESAs in Stage 3-4 Chronic Kidney Disease (CKD).
Interim Analysis of Once-Monthly Hematide Efficacy and Safety in HD Patients Not on ESA Treatment.
Efficacy and Safety of Hematide in Patients with Anti-Erythropoietin (EPO) Antibody-Mediated Pure Red Cell Aplasia (Ab+PRCA).
Intravenous Iron Modulates Platelet Increase in Iron-Deficient Anemic (IDA) Patients with CKD and Chronic Heart Failure (CHF).
CRF by problem area -- Bone disease/Ca-P/PTH
25-Hydroxyvitamin D Levels and Progressive Kidney Disease: Contribution to the Excess Risk of ESRD in Non-Hispanic Blacks.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed Dose Study of AMG 223 in Subjects with CKD on Hemodialysis with Hyperphosphatemia.
A Double-Blind, Randomized, Placebo-Controlled, Study To Evaluate the Effects of AMG 223 on Tolerability and Phosphorus Excretion in Healthy Volunteers.
Associations of Serum Alkaline Phosphatase Levels with Mortality and Hospitalizations in Patients with Normal GFR.
Entry Period and Exposure Windows and Association with Vitamin D Effect in Hemodialysis (HD) Patients.
The Effect of Lanthanum Carbonate (LC) (Fosrenol) on Coronary Artery Calcification (CAC) and Endothelial Function (FMD) in Hemodialysis (HD) Patients. A Pilot, Prospective Study.
Serum Fibroblast Growth Factor 23 (FGF23) Is Associated with Bone Mineral Density (BMD) and Cardiovascular Disease (CVD) in Patients Undergoing Dialysis.
CRF by organ system -- Cardiovascular/Hypertension
Utility of Heart Rate Variability To Identfy High Risk Subset for Cardiovascular Disease among Patients with Chronic Kidney Disease.
Prognostic Value of Heart Rate Variability (HRV) in Chronic Kidney Disease (CKD): The Renal Research Institute (RRI)-CKD Study.
Clinical Usefulness of Cardiac Troponin T for Diagnosing Acute Myocardial Infarction in Patients with Chronic Kidney Disease.

Assessing renal function -- Creatinine clearance
Comparing Cystatin C with AKIN Criteria for Intensive Care Unit AKI.
Plasma Cystatin C Increases before Plasma Creatinine in Intensive Care Unit Patients.
Acid-base/Lytes -- Hyponatremia
The High Incidence of Hyponatremia in Patients Admitted to a Comprehensive Cancer Center: Causes, Severity and Implication for Patient Outcome.
The Effectiveness of Barsoum-Levine Formula for Predicting the Initial Saline Infusion Rates in Severe Hyponatremia greater than or equal to 125 mEq/L).
Hyponatremia-Induced Osteoporosis.
Mortality in Severe Hyponatremia: Do Patients Die ""OF"" or ""WITH"" a Low Serum Sodium Concentration?.
Normal Fractional Urate Excretion (FEurate) in Reset Osmostat (RO) Eliminates RO as Subgroup of SIADH.
Rapid Correction of Chronic Hyponatremia Causes Astrocytes Death.
Assessing renal function -- Urine/plasma creatinine, osmolality, sodium, urea
The Utility of Neutrophil Gelatinase-Associated Lipocalin in Predicting Acute Kidney Injury in a General Adult Intensive Care Unit.
Urinary Neutrophil Gelatinase Associated Lipocalin Distinguishes Type of Kidney Failure and Predicts Mortality in Patients with Cirrhosis.
Urinary Biomarkers Obtained in the Emergency Center (EC) Can Predict AKI in Children.
Etiologic index -- Reduced circulatory volume/sepsis/hepatorenal
Comparison of Novel Early Biomarkers of Acute Kidney Injury (AKI) To Predict the Course and Severity of AKI Developing after Cardiac Surgery.
ARF etiology -- Acute glomerulonephritis/RPGN
Evaluation of Chronologic Serum Anti-Glomerular Basement Membrane Antibodies Prior to Diagnosis of Anti-Glomerular Basement Membrane Disease.
ARF etiology -- Crystal-induced nephropathy
Gout Subjects with Hyperuricemia and Renal Impairment Treated with Febuxostat or Allopurinol for 6 Months.
Proteinuria/Hematuria -- Minimal change disease
NGAL and MMP-7 as Differential Markers of Nephrotic Syndrome.
Efficacy and Safety of Rituximab in Patients with Minimal Change Disease with Contraindication for Steroid Treatment or Dependence of Calcineurin Inhibitors.
Tacrolimus Is an Effective Treatment of De Novo Minimal Change Glomerulonephritis in Adults.
Proteinuria/Hematuria -- Nephrotic syndrome in children
Effective Treatment of Combined Rituximab and Mycophenolate in Children and Adolescents with Refractory Nephrotic Syndrome.
Efficacy of Rituximab in Steroid Dependent and Steroid Resistant Nephrotic Syndrome in Children and Young Adults.
Rituximab in Steroid Sensitive Nephrotic Syndrome.
Proteinuria/Hematuria -- IgA Nephropathy
A Genome Wide Linkage Scan Identifies New QTL (s) Controlling Glycosylation of IgA1 in Familial IgA Nephropathy.
Proteinuria/Hematuria -- Lupus nephritis
Is Rebiopsy Required To Identify Complete Remission in Patients Treated for Lupus Nephritis?.
Treating Relapsing Lupus Nephritis with Rituximab & Mycophenolate Mofetil (MMF) & Minimal Steroids Leads to High Rates of Remission at 2 Years.
Treatment of Lupus Nephritis with Rituximab & Mycophenolate Mofetil but without Oral Steroids Leads to High Rates of Maintained Remission & Low Relapse Rates at 2 and 3 Years.
Oral Cyclophosphamide (POCY) in the Management of Severe Lupus Glomerulonephritis (LN): An Under-Utilized Therapeutic Option.
Geographical Variation of the Response to Mycophenolate Mofetil Induction Therapy in Lupus Nephritis.
Proteinuria/Hematuria -- Diabetes
Normal Range Albuminuria Does Not Exclude Nephropathy in Diabetic Children.
Proteinuria/Hematuria -- Vasculitis (Wegener's PAN, etc.)
Chronological Serum Anti-Neutrophil Cytoplasmic Autoantibodies Prior to the Clinical Presentation of Wegener's Granulomatosis.
Continuous Anti-B-Cell Therapy; Successful Adjunct to Treatment for ANCA- Associated Vasculitis.
Antigen Specificity of ANCA Correlates with Both Clinical Expression and Prognosis in ANCA Small Vessel Vasculitis (SVV).
Maintenance Therapy for ANCA-Associated Systemic Vasculitis.
Pharmacodynamic Drug Monitoring a New Tool for Individualised Immunosuppression in Patients with ANCA-Associated Systemic Vasculitis.
CycLowVas Rituximab (RTX)-Based Cyclophosphamide (CYP)-Sparing Regime Long Term Follow Up.

RW09 Selected Abstract Cumulative List

HDCN home /about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?